[go: up one dir, main page]

DE69636870D1 - KVLQT1 - EIN GEN DES LONG-QT-SYNDROMS, WELCHES FÜR KVLQT1 KODIERT UND WELCHES SICH MIT Mink ZUSAMMENSETZT, UM Iks-KALIUMKANÄLE DES HERZENS ZU BILDEN - Google Patents

KVLQT1 - EIN GEN DES LONG-QT-SYNDROMS, WELCHES FÜR KVLQT1 KODIERT UND WELCHES SICH MIT Mink ZUSAMMENSETZT, UM Iks-KALIUMKANÄLE DES HERZENS ZU BILDEN

Info

Publication number
DE69636870D1
DE69636870D1 DE69636870T DE69636870T DE69636870D1 DE 69636870 D1 DE69636870 D1 DE 69636870D1 DE 69636870 T DE69636870 T DE 69636870T DE 69636870 T DE69636870 T DE 69636870T DE 69636870 D1 DE69636870 D1 DE 69636870D1
Authority
DE
Germany
Prior art keywords
kvlqt1
long
syndrome
gene
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69636870T
Other languages
English (en)
Other versions
DE69636870T2 (de
Inventor
T Keating
C Sanguinetti
E Curran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Utah Research Foundation Inc
Original Assignee
University of Utah Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26691739&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69636870(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by University of Utah Research Foundation Inc filed Critical University of Utah Research Foundation Inc
Publication of DE69636870D1 publication Critical patent/DE69636870D1/de
Application granted granted Critical
Publication of DE69636870T2 publication Critical patent/DE69636870T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69636870T 1995-12-22 1996-12-20 KVLQT1 - EIN GEN DES LONG-QT-SYNDROMS, WELCHES FÜR KVLQT1 KODIERT UND WELCHES SICH MIT Mink ZUSAMMENSETZT, UM Iks-KALIUMKANÄLE DES HERZENS ZU BILDEN Expired - Lifetime DE69636870T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1901495P 1995-12-22 1995-12-22
US19014P 1995-12-22
US73938396A 1996-10-29 1996-10-29
US739383 1996-10-29
PCT/US1996/019756 WO1997023598A2 (en) 1995-12-22 1996-12-20 A long qt syndrome gene which encodes kvlqt1 and its association with mink

Publications (2)

Publication Number Publication Date
DE69636870D1 true DE69636870D1 (de) 2007-03-15
DE69636870T2 DE69636870T2 (de) 2007-11-08

Family

ID=26691739

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69636870T Expired - Lifetime DE69636870T2 (de) 1995-12-22 1996-12-20 KVLQT1 - EIN GEN DES LONG-QT-SYNDROMS, WELCHES FÜR KVLQT1 KODIERT UND WELCHES SICH MIT Mink ZUSAMMENSETZT, UM Iks-KALIUMKANÄLE DES HERZENS ZU BILDEN
DE69637895T Expired - Lifetime DE69637895D1 (de) 1995-12-22 1996-12-20 Ein gen des "langen qt syndroms" (long qt syndrom), welches kvlqt1 kodiert und seine wechselwirkung mit mink

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69637895T Expired - Lifetime DE69637895D1 (de) 1995-12-22 1996-12-20 Ein gen des "langen qt syndroms" (long qt syndrom), welches kvlqt1 kodiert und seine wechselwirkung mit mink

Country Status (11)

Country Link
EP (3) EP2085478A1 (de)
JP (2) JP2001519646A (de)
AT (2) ATE427993T1 (de)
AU (2) AU714041B2 (de)
CA (1) CA2240737C (de)
DE (2) DE69636870T2 (de)
DK (1) DK0876491T3 (de)
ES (1) ES2325820T3 (de)
NZ (2) NZ330744A (de)
PT (1) PT876491E (de)
WO (2) WO1997023598A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277978B1 (en) 1995-12-22 2001-08-21 University Of Utah Research Foundation KVLQT1—a long QT syndrome gene
US6274332B1 (en) * 1995-12-22 2001-08-14 Univ. Of Utah Research Foundation Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene
JP4520634B2 (ja) * 1997-10-24 2010-08-11 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション 良性の家族性新生児痙攣（ｂｆｎｃ）および他の癲癇において突然変異されたｋｃｎｑ２およびｋｃｎｑ３−カリウムチャンネル遺伝子
GB9726339D0 (en) * 1997-12-13 1998-02-11 Zeneca Ltd Human-derived tissue-specific potassium channel
AU747846B2 (en) * 1998-02-25 2002-05-23 Icagen, Inc. Human potassium channel genes
US6071720A (en) 1998-04-29 2000-06-06 Incyte Pharmaceuticals, Inc. Delayed rectifier potassium channel subunit
US6794161B1 (en) 1999-01-26 2004-09-21 Neurosearch A/S Potassium channels and genes encoding these potassium channels
DE60031241T2 (de) * 1999-01-26 2007-02-08 Neurosearch A/S Kaliumkanäle und für diese kaliumkanäle kodierende gene
WO2001024681A2 (en) 1999-08-09 2001-04-12 University Of Utah Research Foundation Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same
US6458542B1 (en) 1999-10-08 2002-10-01 Vanderbilt University Method of screening for susceptibility to drug-induced cardiac arrhythmia
EP1176197A1 (de) * 2000-06-16 2002-01-30 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Transgenes Tiermodel für Herzarrythmien
CA2421584C (en) * 2000-09-06 2013-12-31 Johns Hopkins University Gene therapy for cardiac arrythmias
US8013133B2 (en) * 2003-04-25 2011-09-06 Medtronic, Inc. Genetic modification of targeted regions of the cardiac conduction system
US10917454B1 (en) 2019-08-01 2021-02-09 Rohde & Schwarz Gmbh & Co. Kg System and method for ATC voice quality assurance

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
CA1188246A (en) 1981-08-31 1985-06-04 Jerry L. Gregory Immobilized microbe recycle apparatus
US4868105A (en) 1985-12-11 1989-09-19 Chiron Corporation Solution phase nucleic acid sandwich assay
IE61148B1 (en) 1988-03-10 1994-10-05 Ici Plc Method of detecting nucleotide sequences
IL103059A0 (en) 1991-09-30 1993-02-21 Boehringer Ingelheim Int Conjugates for introducing nucleic acid into higher eucaryotic cells
US5252479A (en) 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
US5599673A (en) * 1995-03-09 1997-02-04 University Of Utah Research Foundation Long QT syndrome genes

Also Published As

Publication number Publication date
AU1742897A (en) 1997-07-17
PT876491E (pt) 2009-07-14
AU1951297A (en) 1997-07-17
DE69637895D1 (de) 2009-05-20
NZ330743A (en) 1999-07-29
JP2001519646A (ja) 2001-10-23
EP0870041A4 (de) 2002-01-23
WO1997023598A3 (en) 1997-09-12
EP2085478A1 (de) 2009-08-05
EP0870041A2 (de) 1998-10-14
WO1997023632A1 (en) 1997-07-03
ATE427993T1 (de) 2009-04-15
CA2240737C (en) 2009-09-29
EP0876491B1 (de) 2009-04-08
AU714041B2 (en) 1999-12-16
CA2240737A1 (en) 1997-07-03
NZ330744A (en) 1999-02-25
EP0870041B1 (de) 2007-01-24
EP0876491A4 (de) 2001-12-19
WO1997023598A2 (en) 1997-07-03
JP3449419B2 (ja) 2003-09-22
DK0876491T3 (da) 2009-07-06
EP0876491A1 (de) 1998-11-11
ATE352629T1 (de) 2007-02-15
AU714527B2 (en) 2000-01-06
JP2001501445A (ja) 2001-02-06
ES2325820T3 (es) 2009-09-18
DE69636870T2 (de) 2007-11-08

Similar Documents

Publication Publication Date Title
DE69636870D1 (de) KVLQT1 - EIN GEN DES LONG-QT-SYNDROMS, WELCHES FÜR KVLQT1 KODIERT UND WELCHES SICH MIT Mink ZUSAMMENSETZT, UM Iks-KALIUMKANÄLE DES HERZENS ZU BILDEN
DE69510810D1 (de) Lamanin-ketten: diagnostische und therapeutische verwendung
DK0991421T3 (da) Påvisning og modulering af IAP'er og NAIP i forbindelse med diagnose og behandling af proliferativ sygdom
EP1612280A3 (de) Diagnose und Behandlung von Williams Syndrom
IL153052A0 (en) Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
WO2016138337A1 (en) Microbiome diagnostics
NO904001L (no) Fremgangsmaate og apparat, for diagnostisk analyse.
BR9712254A (pt) Preparação proteìnica isolada e de htrt, fragmento de proteìna de htrt,telomerase humana,polinucleotìdeo isolado, vetor de expressão, célula,organismo não humano, antocorpo isolado ou recombinante, processos para determinar se um composto ou tratamento é um modulador de uma atividade ou expressão de htrt, se um composto de teste é um modulador de uma atividade de transcriptase reversa de telomerase, para identificar um composto que modula a atividade de htrt, para preparar telomerase recombinante, para detectar um produto de gente de htrt em uma amostra e a presença de pelo menosuma célula humana positiva de telomerase em uma amostra biológica, para diagnosticar uma condição relacionada a telomerase em um paciente e câncer para fornecer um prognóstico para um paciente de câncer, para monitorar a capacidade de um tratamento anti-câncer, para reduzir a capacidade proliferativa das células cancerìgenas em uma paciente, para aumentar a capacidade proliferativa de uma célula de vertebrado, para tratar uma condição associada com um nìvel elevado de atividade de telomerase dentro de uma célula, para isolar um ácido nucleico selecionado de sequência desconhecida,para detectar um produto do gene de htrt em uma amostra e a presença de pelo menos uma célula humana positiva de telomerase em uma amostra biológica, kit para a detecção de um gene ou produto do gene de htrt, composições farmacológica e farmacêutica, vacina, proteìna htrt isolada, usos de um polinucleotìdeo, anticorpo e de um agente de aumento da expressão de htrt, proteìna, variante ou fragmento,e, uso de uma proteìna, polipeptìdeo ou fragmento uso dos mesmos.
EE200100472A (et) Polüpeptiid, antikehad, lahustuv polüpeptiid, polü- või oligonukleotiid ja meetod diferentsiaalseltekspresseerunud DNA järjestuste spetsiifiliseks identifitseerimiseks
DE68928728D1 (de) Diagnose von retinoblastoma
Coppola et al. Why do some Friedreich’s ataxia patients retain tendon reflexes? A clinical, neurophysiological and molecular study
EP0870036A4 (de) Synthetische säugetier alpha-n-aectylglukosaminidase und dafür kodierende genetische sequenzen
Morris et al. Gait and balance in apolipoprotein Ɛ4 allele carriers in older adults and Parkinson’s disease
ATE80465T1 (de) Diagnose von fettleibigkeit, hervorgerufen durch eine genetische abnormalitaet, und verfahren zur therapeutischen behandlung von genetisch bedingter fettleibigkeit.
Lavoie Psychosocial adjustment and personality functioning following postacute rehabilitation.
Lungershausen The Fate of Psychiatric Patients after Discharge from Stationary Therapy

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: DF-MP, 80333 MUENCHEN